Lakeman, I. M. M., Van Den Broek, A. J., Vos, J. A. M., Barnes, D. R., Adlard, J., Andrulis, I. L., . . . Rookus, M. A. (2021). The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Citación estilo ChicagoLakeman, Inge M. M., et al. The Predictive Ability of the 313 Variant–based Polygenic Risk Score for Contralateral Breast Cancer Risk Prediction in Women of European Ancestry With a Heterozygous BRCA1 or BRCA2 Pathogenic Variant. 2021.
Cita MLALakeman, Inge M. M., et al. The Predictive Ability of the 313 Variant–based Polygenic Risk Score for Contralateral Breast Cancer Risk Prediction in Women of European Ancestry With a Heterozygous BRCA1 or BRCA2 Pathogenic Variant. 2021.